Manuscripts
Showing 1595 manuscripts.
Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings
Citation
Infant Outcomes After Maternal Antiretroviral Exposure in Resource-Limited Settings. Pediatrics. 2012 Jun 01; 129(6):e1525-e1532. PMID: 22585772; PMCID: PMC3362906.Year
2012
Journal
Pediatrics
Study
P1054
Three Postpartum Antiretroviral Regimens to Prevent HIV Infection
Citation
Three Postpartum Antiretroviral Regimens to Prevent HIV Infection. New England Journal of Medicine. 2012 Jun 21; 366(25):2368-79. PMID: 22716975; PMCID: PMC3590113.Year
2012
Journal
New England Journal of Medicine
Study
P1043/HPTN 040
Safety and Immunogenicity of a Two-Dose Series of Quadrivalent Meningococcal Conjugate Vaccine in 2 to 10 Year-Old HIV-Infected Children
Citation
Safety and Immunogenicity of a Two-Dose Series of Quadrivalent Meningococcal Conjugate Vaccine in 2 to 10 Year-Old HIV-Infected Children. Pediaric Infectious Disease Journal. 2012 Jan 01; 31(1):47-52. PMID: 21987006; PMCID: PMC3252429.Year
2012
Journal
Pediaric Infectious Disease Journal
Study
P1065
Assessment of Developmental Changes in Infant Lopinavir Pharmacokinetics and its Impact on Weight Band Dosing
Citation
Assessment of Developmental Changes in Infant Lopinavir Pharmacokinetics and its Impact on Weight Band Dosing. Clinical Pharmacology & Therapeutics. 2012 Feb 01; 91(2):243-249. PMID: 22190064; PMCID: PMC3356582.Year
2012
Journal
Clinical Pharmacology & Therapeutics
Study
P1030
Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025
Citation
Jennifer S Read, Yanling Huo, Kunjal Patel, Marcia Mitchell, Gwendolyn B Scott. Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025. Journal of Pediatric Infectious Disease Society. 2012 Jun 01; 1(2):92-102. PMID: 23687574; PMCID: PMC3656554.Year
2012
Journal
Journal of Pediatric Infectious Disease Society
Study
P1025
Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus
Citation
Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with Human Immunodeficiency Virus. Pediatrics. 2012 Oct 01; 161(4):676-81. PMID: 22622049; PMCID: PMC3434315.Year
2012
Journal
Pediatrics
Study
P1065
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
Citation
Tim R Cressey, Alice Stek, Edmund Capparelli, Chureeratana Bowonwatanuwong, Sinart Prommas, Pannee Sirivatanapa, Prapap Yuthavisuthi, Chanon Neungton, Yanling Huo, Elizabeth Smith, Brookie M Best, Mark Mirochnick, IMPAACT P1026s Team. Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum. Journal of Acquired Immune Deficiency Syndromes. 2012 Mar 01; 59(3):245-252. PMID: 22083071; PMCID: PMC3288559.Year
2012
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Dynamics of the resting CD4+ T cell latent HIV reservoir in infants initiating highly active antiretroviral therapy less than six months of age
Citation
Dynamics of the resting CD4+ T cell latent HIV reservoir in infants initiating highly active antiretroviral therapy less than six months of age. AIDS. 2012 Jul 31; 26(12):1483-90. PMID: 22555165; PMCID: PMC3495308.Year
2012
Journal
AIDS
Study
P1030
Longitudinal Study of Incidence and Predictors of Mental Health Concerns in Youth Perinatally-Infected with HIV and Controls
Citation
Longitudinal Study of Incidence and Predictors of Mental Health Concerns in Youth Perinatally-Infected with HIV and Controls. Journal Of Developmental and Behavioral Pediatrics. 2012 Jul 01; 33(6):456-68. PMID: 22772819.Year
2012
Journal
Journal Of Developmental and Behavioral Pediatrics
Study
P1055
CNS Vasculopathy in HIV-Infected Children Enrolled in the PACTG 219/219C Study
Citation
CNS Vasculopathy in HIV-Infected Children Enrolled in the PACTG 219/219C Study. Pediaric Infectious Disease Journal. 2012 Oct 26;Year
2012
Journal
Pediaric Infectious Disease Journal